Cutting-edge bayesian deep learning and statistical strategies for bias mitigation in COVID-19 detection via chest x-ray imaging.

Cutting-edge bayesian deep learning and statistical strategies for bias mitigation in COVID-19 detection via chest x-ray imaging.

Publication date: Dec 14, 2025

Chest radiography (CXR is widely used for triage and follow-up of pulmonary disease, yet COVID-19 classification remains vulnerable to bias, label noise, and domain shift. We propose a multi-stage Bayesian deep learning framework that combines lung segmentation, segmentation-guided classification, calibrated ensembling, and uncertainty estimation to classify four classes (COVID-19, normal, viral pneumonia, bacterial pneumonia) and to grade COVID-19 severity. Models are trained and tested on 1,531 CXRs (100 COVID-19 images from 70 patients; 1,431 non-COVID images from ChestX-ray14) with patient-wise splits. The final ensemble achieves 98. 33% test accuracy; COVID-19 sensitivity reaches 100% on this split. Robustness is quantified by stress-testing five image degradations (Gaussian noise, motion/defocus blur, JPEG compression, and downsampling), with macro AUC drops remaining small at moderate severities and larger under strong blur or heavy downsampling. Saliency and context-relevance analyses are used to identify spurious cues. The study is limited by dataset size and lack of external multi-site validation; a planned evaluation on COVIDx and BIMCV-COVID19 + is outlined.

Open Access PDF

Concepts Keywords
Patient Baysian deep learning
Pneumonia Chest X-ray images
Viral COVID-19 detection
Pneumonia classification
Statisical analysis

Semantics

Type Source Name
disease MESH COVID-19
disease MESH pulmonary disease
disease MESH pneumonia bacterial
disease MESH pneumonia
disease MESH image
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Coenzyme M
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH infections
disease MESH emergency
disease MESH coronavirus infection
disease MESH diarrhea
disease MESH fever
disease MESH pneumothorax
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Gold
drug DRUGBANK Methionine
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Flunarizine
disease MESH Ii+mj+nc
disease MESH Acc
drug DRUGBANK Saquinavir
disease MESH confusion
disease MESH viral pneumonia
disease MESH plan
drug DRUGBANK Spinosad
disease MESH APC
drug DRUGBANK Hexachlorophene
disease MESH secondary infection
disease MESH Dis
disease MESH Pulmonary Arterial Hypertension
disease MESH severe acute respiratory syndrome
disease MESH infertility
pathway REACTOME Fertilization
disease MESH viral infections
drug DRUGBANK Etodolac
pathway REACTOME Influenza Infection
drug DRUGBANK Guanosine
pathway KEGG Coronavirus disease
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH sepsis
drug DRUGBANK Omadacycline
disease MESH Sweet syndrome
drug DRUGBANK Lauric Acid
disease MESH Brain tumor
disease MESH Community acquired Pneumonia
disease MESH cmc
drug DRUGBANK Trestolone

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *